These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25376116)

  • 1. Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma.
    Herman MP; Dagan R; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Mendenhall WM
    Laryngoscope; 2015 Mar; 125(3):630-5. PubMed ID: 25376116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
    Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
    Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins.
    Lapeyre M; Bollet MA; Racadot S; Geoffrois L; Kaminsky MC; Hoffstetter S; Dolivet G; Toussaint B; Luporsi E; Peiffert D
    Head Neck; 2004 Mar; 26(3):216-23. PubMed ID: 14999796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Close margin alone does not warrant postoperative adjuvant radiotherapy in oral squamous cell carcinoma.
    Ch'ng S; Corbett-Burns S; Stanton N; Gao K; Shannon K; Clifford A; Gupta R; Clark JR
    Cancer; 2013 Jul; 119(13):2427-37. PubMed ID: 23576156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy.
    Liao CT; Lin CY; Fan KH; Huang SF; Chen IH; Kang CJ; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Yen TC
    Ann Surg Oncol; 2011 Sep; 18(9):2569-78. PubMed ID: 21360248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.
    Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):137-48. PubMed ID: 9300748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
    Sklenicka S; Gardiner S; Dierks EJ; Potter BE; Bell RB
    J Oral Maxillofac Surg; 2010 Jun; 68(6):1270-5. PubMed ID: 20347201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of early oral squamous cell carcinoma with positive or close margins: relevance of adjuvant treatment in relation to local recurrence: margins of 3 mm as safe as 5 mm.
    Dik EA; Willems SM; Ipenburg NA; Adriaansens SO; Rosenberg AJ; van Es RJ
    Oral Oncol; 2014 Jun; 50(6):611-5. PubMed ID: 24630900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity.
    Chen PY; Chen HH; Hsiao JR; Yang MW; Hsueh WT; Tasi ST; Lin FC; Wu YH
    Oral Oncol; 2012 Aug; 48(8):747-52. PubMed ID: 22401870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity.
    Koo BS; Lim YC; Lee JS; Choi EC
    Oral Oncol; 2006 Sep; 42(8):789-94. PubMed ID: 16455287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
    Fan KH; Wang HM; Kang CJ; Lee LY; Huang SF; Lin CY; Chen EY; Chen IH; Liao CT; Chang JT
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1024-9. PubMed ID: 20610038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
    Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e215-22. PubMed ID: 21531515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.
    George JR; Yom SS; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):1603-8. PubMed ID: 24318221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
    Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
    Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.
    Liao CT; Lin CY; Fan KH; Wang HM; Ng SH; Lee LY; Hsueh C; Chen IH; Huang SF; Kang CJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):284-90. PubMed ID: 21075550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.